Information Journal Paper
APA:
Copy. (2019). lncRNA-CCDC26, as a novel biomarker, predicts prognosis in acute myeloid leukemia. ONCOLOGY LETTERS, 18(3), 2203-2211. SID. https://sid.ir/paper/1025026/en
Vancouver:
Copy. lncRNA-CCDC26, as a novel biomarker, predicts prognosis in acute myeloid leukemia. ONCOLOGY LETTERS[Internet]. 2019;18(3):2203-2211. Available from: https://sid.ir/paper/1025026/en
IEEE:
Copy, “lncRNA-CCDC26, as a novel biomarker, predicts prognosis in acute myeloid leukemia,” ONCOLOGY LETTERS, vol. 18, no. 3, pp. 2203–2211, 2019, [Online]. Available: https://sid.ir/paper/1025026/en